loading
Galectin Therapeutics Inc stock is traded at $5.99, with a volume of 74,696. It is up +5.29% in the last 24 hours and up +37.88% over the past month. Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
See More
Previous Close:
$5.67
Open:
$5.7
24h Volume:
74,696
Relative Volume:
0.24
Market Cap:
$383.72M
Revenue:
-
Net Income/Loss:
$-45.08M
P/E Ratio:
-8.2055
EPS:
-0.73
Net Cash Flow:
$-33.68M
1W Performance:
+16.83%
1M Performance:
+37.88%
6M Performance:
+355.73%
1Y Performance:
+129.17%
1-Day Range:
Value
$5.6599
$6.00
1-Week Range:
Value
$5.05
$6.25
52-Week Range:
Value
$0.726
$6.55

Galectin Therapeutics Inc Stock (GALT) Company Profile

Name
Name
Galectin Therapeutics Inc
Name
Phone
678-620-3186
Name
Address
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Name
Employee
15
Name
Twitter
@galectingalt
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
GALT's Discussions on Twitter

Compare GALT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GALT
Galectin Therapeutics Inc
5.99 365.60M 0 -45.08M -33.68M -0.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
417.62 107.10B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
630.39 66.00B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
429.66 55.95B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
827.14 51.19B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
185.46 38.98B 447.02M -1.18B -906.14M -6.1812

Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-17-25 Resumed H.C. Wainwright Buy
Aug-13-20 Reiterated H.C. Wainwright Buy
Feb-13-19 Initiated B. Riley FBR Buy
Dec-07-17 Reiterated H.C. Wainwright Buy
Nov-28-17 Reiterated H.C. Wainwright Buy
Oct-19-17 Initiated ROTH Capital Buy
Mar-30-17 Upgrade H.C. Wainwright Neutral → Buy
Oct-03-16 Downgrade FBR & Co. Outperform → Mkt Perform
Sep-29-16 Downgrade H.C. Wainwright Buy → Neutral
Sep-28-16 Downgrade ROTH Capital Buy → Sell
Mar-28-16 Resumed H.C. Wainwright Buy
Sep-21-15 Initiated H.C. Wainwright Buy
Aug-01-14 Downgrade Aegis Capital Buy → Hold
Jul-30-14 Reiterated MLV & Co Buy
Jul-29-14 Reiterated MLV & Co Buy
Apr-02-14 Reiterated MLV & Co Buy
Feb-10-14 Reiterated Aegis Capital Buy
Jan-09-14 Reiterated Aegis Capital Buy
Dec-03-13 Initiated MLV & Co Buy
Aug-19-13 Reiterated Aegis Capital Buy
View All

Galectin Therapeutics Inc Stock (GALT) Latest News

pulisher
02:37 AM

Can you recover from losses in Galectin Therapeutics Inc.2025 Breakouts & Breakdowns & Consistent Income Trade Ideas - newser.com

02:37 AM
pulisher
01:57 AM

Applying Elliott Wave Theory to Galectin Therapeutics Inc.2025 Price Targets & Entry Point Confirmation Alerts - newser.com

01:57 AM
pulisher
12:52 PM

Is Galectin Therapeutics Inc. (PHPN) stock among top earnings plays2025 Analyst Calls & Weekly High Return Forecasts - newser.com

12:52 PM
pulisher
12:30 PM

What sentiment indicators say about Galectin Therapeutics Inc. stock2025 Sector Review & Community Consensus Trade Alerts - newser.com

12:30 PM
pulisher
Nov 04, 2025

Galectin Therapeutics (NASDAQ:GALT) Stock Passes Above 200-Day Moving AverageTime to Sell? - MarketBeat

Nov 04, 2025
pulisher
Nov 03, 2025

What valuation multiples suggest for Galectin Therapeutics Inc. stock2025 Price Targets & Entry Point Confirmation Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What is the fair value estimate for Galectin Therapeutics Inc. (PHPN) stock in 2025Day Trade & Community Consensus Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Galectin Therapeutics Inc. (PHPN) stock sustain margin levelsGDP Growth & Daily Entry Point Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Galectin Therapeutics Inc. forming a reversal patternTrade Risk Summary & Community Trade Idea Sharing - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Identifying reversal signals in Galectin Therapeutics Inc.Options Play & Free Growth Oriented Trading Recommendations - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Is Galectin Therapeutics Inc. (PHPN) stock cheap by valuation metrics2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Will Galectin Therapeutics Inc. (PHPN) stock beat growth indexesJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com

Oct 31, 2025
pulisher
Oct 28, 2025

Will Galectin Therapeutics Inc. stock benefit from green energy trends2025 Fundamental Recap & Long-Term Investment Growth Plans - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

Why Galectin Therapeutics Inc. (PHPN) stock could rally stronglyJuly 2025 Big Picture & Free Weekly Chart Analysis and Trade Guides - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Galectin Therapeutics Inc. (GALT) Stock forecasts - Yahoo! Finance UK

Oct 27, 2025

Galectin Therapeutics Inc Stock (GALT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Galectin Therapeutics Inc Stock (GALT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
CALLICUTT JACK W
Chief Financial Officer
Sep 12 '25
Option Exercise
1.37
8,706
11,927
16,320
CALLICUTT JACK W
Chief Financial Officer
Sep 12 '25
Sale
6.44
8,706
56,054
7,614
LEWIS JOEL
President and CEO
Sep 12 '25
Option Exercise
2.39
14,000
33,460
846,592
LEWIS JOEL
President and CEO
Sep 12 '25
Sale
6.36
14,000
89,048
832,592
$39.90
price up icon 5.28%
$28.38
price down icon 1.47%
$103.61
price up icon 0.69%
$104.07
price down icon 0.74%
biotechnology ONC
$307.49
price down icon 0.37%
$185.46
price up icon 1.30%
Cap:     |  Volume (24h):